Fertility Supplements Market Size, Share & Trends Analysis Report By Ingredient (Natural, Synthetic/Blend), By Product (Capsules, Tablets, Soft Gels), By End-use, By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2030

Report Overview

The global fertility supplements market size was valued at USD 1.77 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.9% from 2022 to 2030. The declining fertility rates brought on by the rise in the number of smokers as well as the rising consumption of alcohol and caffeine are predicted to fuel the market growth in the coming years. The demand for the product has been driven by factors such as rising healthcare costs, changing lifestyles, food innovation, and medical advancements. Furthermore, the global market for fertility supplements is expanding as a result of women's delayed pregnancies and ongoing declines in fertility rates. The COVID-19 pandemic had a positive impact on the demand for fertility supplements because it was found that the COVID-19 virus had an impact on a person's level of fertility. Furthermore, according to the article "Potential Role of Zinc in the COVID-19 Disease Process and its Probable Impact on Reproduction", published in January 2021, zinc supplements can restrict or minimize damage to egg and sperm cells caused by the body's immune response to the coronavirus by enhancing immunity. Such studies have increased the demand for fertility supplements during the pandemic, which had a positive impact on the market.

The American Society for Reproductive Medicine estimates that 35% of men and 30% of women in their reproductive age smoke cigarettes in the U.S. Developed nations have a higher smoking prevalence than emerging economies. Some fertility treatments including IVF may not be helpful for conceiving for women who smoke owing to the fact that smoking can hinder fertility. As a result, manufacturers of fertility products are searching for ingredients that can reverse the effects of smoking on fertility. Therefore, this factor will offer manufacturers of fertility supplements in the country expansion opportunities over the estimated timeframe.

The growing use of foods such as olive oil, whole grains, avocados, and high-fat dairy products to increase fertility is predicted to expand the market for functional foods and beverages in the near future, which may slow overall industry growth. However, growing consumer concern over the negative side effects of conventional pharmaceutical drugs is expected to increase the use of herbal (or botanical) medicines, which will benefit product manufacturers. Consumers are now more likely to choose supplements based on what is best for their health rather than impressive marketing and packaging owing to a number of government initiatives to raise awareness regarding the developments in supplement research and advanced technology.

The growing preference for infertility prevention measures, such as maintaining a healthy diet and rising consumption of nutritional supplements, is fueling industry growth. In addition, the rise in infertility rates is caused by a number of illnesses, including sexually transmitted diseases (STDs) and conditions that affect fertility. Therefore, it is anticipated that the market for fertility supplements will grow more rapidly as infertility rates rise in the near future. Consumers from Argentina and Brazil have been recently focusing on enhancing their sexual health and well-being. As a result, people are willing to spend more money on the appropriate products. Therefore, is anticipated that the demand for fertility supplements will rise over the coming years.

Ingredient Insights

The synthetic segment held the largest revenue share of over 85.0% in 2021. Selenium, zinc, folic acid, vitamin C, vitamin B6, CoQ1, and Myo-Inositol are the major synthetic ingredients that contributed significantly to overall growth due to increased demand and easy availability.

The natural segment is predicted to expand at a significant CAGR of 10.0% from 2022 to 2030. The introduction of novel products and technological innovations in the health and wellness sector is anticipated to spur the growth of the natural fertility supplement market in the coming years. The demand is anticipated to increase in the near future as people are increasingly using products made from plants to maintain a healthy lifestyle as well as lower their risk of developing side effects. There is a rising demand for plant extracts, particularly herbs, in the pharmaceutical industry due to increased awareness regarding biologically-derived ingredients. This is expected to reduce raw material availability among natural food product manufacturers over the next few years. Despite the rapidly expanding growth of natural ingredients, a lack of scientific support for the claims is limiting segment growth. Several governments have funded studies to increase natural product adoption, which is expected to drive product demand over the forecast period.

End-use Insights

The women segment held the largest share of over 55.0% in 2021. According to the Centers for Disease Control and Prevention, about 19% of women between 15-49 years of age with no prior births suffer from infertility issues. However, fertility issues were the most prevalent among married infertile women aged 40 to 44, followed by women aged 35 to 39. Initiatives by the government and non-profit organizations to provide advice and medical assistance have helped raise awareness, resulting in opportunities for product manufacturers in the market.

The men segment is anticipated to expand at a CAGR of 9.4% during the forecast period. Some of the most common causes of infertility in men are hypogonadism, immune system factors, varicocele, systemic disease, sexual factors, undescended testicles, and urogenital infection. The male is solely responsible for about 20% of all infertility cases and is also a contributing factor in another 30% to 40%. According to a paper published in the National Library of Medicine about Male Fertility in 2022, the male factor is significantly contributing to about 50% of all cases of infertility, which is anticipated to boost product demand in this segment over the forecast period.

Distribution Channel Insights

In 2021, over-the-counter distribution accounted for the largest share more than 75.0%. Due to the rising demand, easy availability of raw materials, and lenient regulations, the market is fragmented. To enter this highly competitive market, companies must concentrate on incorporating FDA-regulated ingredients that have undergone a considerable number of clinical trials or studies. One of the key trends in the OTC segment is self-medication for the treatment of fertility issues. Additionally, the factors such as cost-effectiveness and convenience of direct purchase are expected to create opportunities for OTC fertility supplement manufacturers in the near future.

The prescribed segment is expected to expand at a lucrative CAGR of 10.8% from 2022 to 2030. Stringent regulations by the governing bodies in some regions, lack of surety regarding the efficacy of products not prescribed by a medical professional, and less awareness among individuals are expected to augment the demand for prescribed fertility supplements. In addition, increasing R&D expenditure, coupled with funding from the public and private sectors, is expected to boost the demand for prescribed fertility supplements over the forecast period.

Product Insights

The capsules segment held the largest share of over 40.0% in 2021. The powder segment is expected to expand at a CAGR of 10.2% during the forecast period due to increased awareness regarding the nutritional benefits offered by these products and delicious flavors and ease of incorporation into meals. These products allow for unique ingredient combinations, reduce gastrointestinal irritation, protect against sensitive ingredients, and ensure oil as well as fat-soluble nutrient delivery. This factor is expected to benefit segment growth. However, the high costs associated with the blistering packaging method are expected to deter manufacturers from using capsule formulation during the projected timeframe.

The tablets segment emerged as the second-largest product segment in 2021. Excipients in high-quality supplements aid in tablet absorption and disintegration. Even though the natural coating improves dissolution, other factors such as efficacy and quality influence absorption. All these factors are expected to drive the demand for fertility supplements in the form of tablets over the forecast period. Furthermore, the product's ease of absorption, cost-effectiveness, and disintegration are expected to fuel segment growth. The size of tablets, however, is a disadvantage because they are difficult to swallow and do not provide the dosing flexibility that liquids and powders offer, which is expected to limit growth in the near future.

Regional Insights

In 2021, North America held the largest revenue share of over 35.0%. According to data from the Centers for Disease Control and Prevention (CDC) December 2021 update, 13.1% of women aged 15 to 49 in the U.S. had impaired fertility, 14.1% of married women aged 15 to 49 had impaired fertility, and 6% of married women were found to be infertile, boosting product demand in the region. Moreover, the market in Canada is expected to grow rapidly due to increased initiatives by the government and nonprofit organizations such as Fertility Matters Canada to raise awareness about fertility medication and treatment and the rising rate of obesity and sexually transmitted infections.

Asia Pacific is expected to expand at a significant CAGR of 11.0% from 2022 to 2030. The region offers lucrative opportunities for leading companies in the fertility supplement market due to the increased availability and accessibility of healthcare facilities and increased expenditure in the research and healthcare sectors. Rising nutritional enrichment awareness in India and China is anticipated to be a significant factor for regional growth. Furthermore, the expansion of the retail market in countries such as India, China, Indonesia, and Malaysia as a result of regulatory support to encourage investment is expected to increase buyer accessibility over the forecast period, which will help the market grow in the region.

Key Companies & Market Share Insights

Manufacturers are focusing on improving the treatment experience and success rates. Companies such as TTK HealthCare, Orthomol, and Fairhaven Health are focusing on expanding and innovating their product portfolios to help people who want to conceive. Companies are continuing to advance fertility supplement innovation in order to increase success rates through life cycle management, which includes new combinations and new indications. For example, in April 2022, Wellbeing Nutrition introduced SLOW, a time-conscious line of nutraceuticals for both women and men. It consists of 13 supplements, designed purely for a variety of distinct wellness and health needs including fertility support.

Leading fertility supplement manufacturers are focusing on developing new products by investing in R&D and technological advancement to provide cost-effective, high-quality products that match the market trends such as non-GMO and organic. Industry participants are also involved in joint ventures, mergers & acquisitions, and partnerships to expand their market share as well as geographical reach. For instance, Dadi, a sperm collection as well as testing startup, was acquired by Online pharmacy Ro for nearly USD 100 million in March 2022. With this acquisition, the company expands its presence in the fertility supplement markets, particularly for erectile dysfunction. Some prominent players in the global fertility supplements market include:

• Fairhaven Health

• Coast Science

• Lenus Pharma GesmbH

• Active Bio Life Science GmbH

• Orthomol

• Exeltis USA, Inc.

• PregPrep LLC

• Bionova

• Vitabiotics Ltd.

• TTK Healthcare Ltd.

• Fertility Nutraceuticals LLC

• extreme V, Inc.

• VH Nutrition LLC

• CellOxess LLC

• Gonadosan

• Amino Expert (Innovamed Ltd.)

• Babystart Ltd.

• Crown Nutraceuticals

• Sal Nature

• YadTech

Fertility Supplements Market Report Scope

Global Fertility Supplements Market Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2030. For this study, Grand View Research has segmented the global fertility supplements market report on the basis of ingredient, product, end-use, distribution channel, and region:

• Ingredient Outlook (Revenue, USD Million, 2017 - 2030)

  • Natural

  • Synthetic/ Blend of Natural & Synthetic

• Product Outlook (Revenue, USD Million, 2017 - 2030)

  • Capsules

  • Tablets

  • Soft Gels

  • Powder

  • Liquids

• End-use Outlook (Revenue, USD Million, 2017 - 2030)

  • Men

  • Women

• Distribution Channel Outlook (Revenue, USD Million, 2017 - 2030)

  • OTC

  • Prescribed

• Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • France

    • Italy

    • U.K.

  • Asia Pacific

    • China

    • India

    • Japan

  • Central & South America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia